- Home
- CNMD vs BXMX Comparison
CNMD vs BXMX Comparison
Compare CNMD & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNMD | BXMX |
|---|---|---|
| Founded | 1970 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNMD | BXMX |
|---|---|---|
| Price | $43.35 | $14.69 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $53.67 | N/A |
| AVG Volume (30 Days) | ★ 588.6K | 205.6K |
| Earning Date | 01-28-2026 | 01-01-0001 |
| Dividend Yield | 1.84% | ★ 7.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.05 | N/A |
| Revenue | ★ $1,347,470,000.00 | N/A |
| Revenue This Year | $6.81 | N/A |
| Revenue Next Year | $0.64 | N/A |
| P/E Ratio | $21.21 | ★ N/A |
| Revenue Growth | ★ 4.61 | N/A |
| 52 Week Low | $38.32 | $11.75 |
| 52 Week High | $74.70 | $13.75 |
Technical Indicators
Market Signals| Indicator | CNMD | BXMX |
|---|---|---|
| Relative Strength Index (RSI) | 60.58 | 62.45 |
| Support Level | $40.15 | $14.63 |
| Resistance Level | $41.62 | $14.84 |
| Average True Range (ATR) | 1.32 | 0.14 |
| MACD | 0.50 | 0.04 |
| Stochastic Oscillator | 82.48 | 81.02 |
Price Performance
Historical ComparisonAbout CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.